News Hub

DEERFIELD, Ill.--The board of directors of Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today declared a regular quarterly dividend of 36 cents per share, a 6.7 percent increase over the year ago...

Walgreens Boots Alliance, Inc. will release its fiscal 2015 fourth quarter and full year earnings results at 7 a.m. Eastern time Wednesday, 28 October 2015.

Third year of program enables Walgreens customers to help protect millions of children in developing countries from polio and measles

Agreement to bring retail clinic expansion to Oregon and Washington under new collaborative services model

More than 90 percent of patients receiving flu shots at Walgreens have insurance to cover vaccination costs Flu Index recaps states and markets hardest hit by flu last season

6 August 2015 (Brussels, Belgium) - The Dennis & Mireille Gillings Foundation has pledged €1 million to the European Organisation for Research and Treatment of Cancer (EORTC) Research Fund to help fight cancer, particularly breast cancer. Part of the donation will support the SPECTAcolor Biobank, a tumour tissue sample Biobank and biomarker analysis platform for genetic profiling of patients suffering from advanced cancer. In supporting this Biobank, the Dennis & Mireille Gillings Foundation will join forces with Walgreens Boots Alliance, which has a long-term partnership with the EORTC Cancer Research Fund.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today named Kimberly R. Scardino as its new senior vice president, global controller and chief accounting officer, effective today.

Purchase of Select Unilever Products at Walgreens to Trigger Donation of Clean Water Overseas*